TAp63/miR-200/Fascin信号通路调控膀胱癌细胞侵袭转移的机制研究

基本信息
批准号:81372722
项目类别:面上项目
资助金额:60.00
负责人:毕建斌
学科分类:
依托单位:中国医科大学
批准年份:2013
结题年份:2017
起止时间:2014-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:刘涛,陈启光,沈海林,荆宏伟,于健,刘炀,张乃文,刘东方,王建峰
关键词:
成束蛋白miR200膀胱癌侵袭转移TAp63
结项摘要

MicroRNAs (miRNAs) play important roles in tumor invasion and metastasis. Identification of tumor metastasis-related miRNAs and signaling pathway has become an important focus of cancer research.Our previous results confirmed the importance of Fascin in the development of bladder tumor and the potential of invasion and metastasis. Further investigation showed that activation of p63 downregulated the Fascin via induction of the miR-200 genes. candidate miRNAs(miR-200a/c) targeting the 3'-untranslated region of Fascin could inhibit Fascin expression and decrease the invasion of T24 cells . On the basis of these data, we hypothesized that TAp63 -mediated miR-200a/c expression may decrease the potential of invasion and migration of bladder cancer cells by directly down-regulating expression of Fascin. In this project, we aimed to a further investigate the direct targeted regulation of Fascin by TAp63/ miR-200a/c through a series of molecular biology methods such as dual-luciferase reporter assay, immunofluorescence localization, gene silencing, immunoblotting test and gene microarray. Furthermore, in vitro and in vivo experiments were conducted to illustrate the molecular mechanism underlying the inhibition of Fascin-conferred invasion and metastasis by TAp63/ miR-200a/c. The findings of this study may have important implications in demonstrating the mechanism of post-transcriptional regulation of Fascin and identification of new therapeutic targets for therapy for muscle-invasive bladder cancer.

鉴定以microRNA为核心的信号通路已成为肿瘤侵袭转移调控领域的核心问题。申请者在前期工作中阐明了成束蛋白(Fascin)在促进膀胱癌细胞恶性发展和侵袭迁移能力方面的重要作用,进而发现抑癌基因TAp63在转录活化miR-200的同时,也抑制了Fascin蛋白的表达。miR-200的"种子区域"序列与Fascin3'UTR 区序列完全匹配,而过表达miR-200a/c模拟物抑制Fascin表达并减少了T24细胞的侵袭迁移。由此我们提出假说:TAp63转录活化的miR-200a/c靶向下调Fascin表达,进而抑制了膀胱癌细胞侵袭转移。本研究拟进一步采用荧光素酶报告基因分析等分子生物学方法,结合功能实验,旨在获得TAp63/miR-200a/c 直接调控Fascin 相关侵袭转移信号通路的可靠证据。本项目将有助于阐明Fascin负性调控机制,为鉴定侵袭性膀胱癌的新治疗靶点提供充分的科学依据。

项目摘要

膀胱癌是泌尿系最常见的恶性肿瘤,其发生发展的分子机制尚不完全明确。由于对TAp63的研究出现困难,鉴于课题时间有限,我们调整了研究方向。我们经研究发现长链非编码RNA ZEB1-AS1在膀胱癌组织中较癌旁组织高表达,其在膀胱癌中可能作为一种癌基因而存在,而miR-200在多种肿瘤中是作为一种抑癌因子而存在,本研究旨在揭示膀胱癌中二者之间的调控关系。我们的结果显示ZEB1-AS1可以促进膀胱癌细胞的侵袭迁移、增殖,并可通过海绵吸附作用吸附miR-200,间接升高miR-200的靶基因FSCN1的表达进而发挥其促进细胞侵袭迁移的功能。本研究的结论是长链非编码RNA ZEB1-AS1可能通过miR-200/FSCN1信号通路对膀胱癌的发生发展起到促进的作用,为膀胱癌的诊治提供新的思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
2

结直肠癌肝转移患者预后影响

结直肠癌肝转移患者预后影响

DOI:10.3969 /j.issn.1002-266X.2016.23.023
发表时间:2016
3

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

DOI:10.3389/fcell.2021.650666
发表时间:2021
4

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

DOI:10.3872/j.issn.1007-385x.2020.02.005
发表时间:2020
5

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

DOI:10.1177/2058738419841481
发表时间:2019

毕建斌的其他基金

相似国自然基金

1

ETK/EZH2信号通路调节膀胱癌细胞侵袭转移的实验研究

批准号:81202013
批准年份:2012
负责人:郭胜杰
学科分类:H1809
资助金额:23.00
项目类别:青年科学基金项目
2

Fascin-1参与喉鳞癌细胞侵袭运动及转移的分子机制研究

批准号:30901665
批准年份:2009
负责人:邹剑
学科分类:H1819
资助金额:20.00
项目类别:青年科学基金项目
3

RI作用ILK介导的信号转导通路在膀胱癌侵袭转移中的机制研究

批准号:81071719
批准年份:2010
负责人:陈俊霞
学科分类:H1809
资助金额:10.00
项目类别:面上项目
4

MT-12对膀胱癌细胞侵袭和转移的影响及机制

批准号:81460385
批准年份:2014
负责人:杨德林
学科分类:H1814
资助金额:47.00
项目类别:地区科学基金项目